Mr. Gerald Tritt reports

JOLT HEALTH INC. ANNOUNCES APPOINTMENT TO THE BOARD

Jolt Health Inc. has appointed Chris Farnworth to its board of directors as an independent director.

Mr. Farnworth brings extensive expertise in business development and corporate finance to the board, with a strong focus on the global mining and energy transition sectors. He previously served as vice-president of business development at a Top 50 TSX Venture Exchange company, where he played a pivotal role in securing initial project financing, leading asset acquisitions and advancing project development initiatives.

A notable highlight of his career includes structuring and executing a successful joint venture with a private equity firm, resulting in significant operational consolidation and value creation. Mr. Farnworth also held the role of vice-president of business development at Noram Lithium, where he was instrumental in advancing the Clayton Valley lithium clay project, one of the most prominent lithium assets in the United States.

Currently, Mr. Farnworth is the founder and chief executive officer of Zero Carbon Technologies, a United Kingdom-based clean-technology company specializing in battery and e-waste recycling, with active operations in Spain and an expanding international footprint. His deep industry knowledge, combined with a robust global network across mining, recycling and capital markets, underpins his commitment to identifying and executing international opportunities within the rapidly evolving green energy and circular economy sectors.

Concurrent with the above appointment, Douglas Taylor has resigned as a member of the company's board of directors. The company thanks Mr. Taylor for his contributions and wishes him well in future endeavours.

About Jolt Health Inc.

Jolt Health is a leading life sciences company focused on health care, biotechnology and artificial intelligence. The company currently holds exclusive licences for innovative therapeutic and pharmaceutical products throughout Europe, the United Kingdom and North America. The company is committed to transforming the industry through research, collaboration and technological advancement, shaping the future of health care worldwide.

We seek Safe Harbor.